Stay updated on pIL-12/MK-3475 Combo for Melanoma Clinical Trial
Sign up to get notified when there's something new on the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page.

Latest updates to the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision label was updated from v3.4.2 to v3.4.3. This appears to be a minor metadata update and does not modify the study details or results.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. This appears to be a minor UI/metadata update without changes to the study details or page functionality.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision indicator updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded a glossary display option and new QC metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) plus a Revision: v3.4.0 tag. Older QC terms (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows Revision: v3.3.4 in place of Revision: v3.3.3.SummaryDifference0.1%

- Check65 days agoChange DetectedThe related topics section now includes Melanoma and MedlinePlus Genetics.SummaryDifference0.2%

Stay in the know with updates to pIL-12/MK-3475 Combo for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page.